{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

PickleJar Entertainment Group, Inc. Announces Completion of Audited Financial Statements for Fiscal Years 2024 and 2023

April 28, 2026PCAOB-Registered Firm Issues Unqualified Audit Opinion; Fiscal 2024 Revenue Grew 138%; Operational Loss Narrowed 45% HOUSTON, TX - April 28, 2026 (NEWMEDIAWIRE) - PickleJar Entertainment Group, Inc. (OTC Pink: PKLE) (“PickleJar” or the “Company”), a music and entertainment software company, today announced the completion of the audit of its financial statements for the fiscal years ended December 31, 2024 and December 31, 2023.


Focus Universal Unveils a New Class of Artificial Intelligence With Relation to the Breakthrough SEC Financial Reporting Software

April 28, 2026WEST COVINA, CA - April 28, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) ("Focus" or the "Company"), a provider of patented hardware and software technologies for IoT, 5G, and AI-driven SEC financial reporting automation, today announced the development of Deterministic AI - a new class of artificial intelligence that addresses the limitations of Generative AI and represents a breakthrough in task execution AI as opposed to consultative AI, especially with relation to financial software and financial reporting.


NeuroOne® to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time

April 28, 2026EDEN PRAIRIE, MINN. - April 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, will release financial results for its fiscal second quarter ended March 31, 2026, before market open on May 12, 2026.


Standard Chartered GBA Business Confidence Indices Highlight Resilience of GBA Corporates Despite Middle East Uncertainties

April 28, 2026Hong Kong Expected to Maintain Its Solid Performance HONG KONG - April 28, 2026 (NEWMEDIAWIRE) - Standard Chartered and the Hong Kong Trade Development Council (HKTDC) jointly released the latest Standard Chartered Greater Bay Area Business Confidence Index (GBAI), revealing that business sentiment among companies in the Greater Bay Area (GBA) remained stable in the first quarter of 2026 despite ongoing geopolitical and trade headwinds, notably oil price shocks and continued repercussions from the Middle East conflict. Maintaining Momentum Amid Headwinds The Q1 findings largely captured activity and business sentiment since the Middle East conflict began in late February, which has remained highly uncertain and weighed on overall business and market sentiment.


HKTDC's Seven Flagship Lifestyle and Licensing Events Open Today

April 28, 2026Licensing Opportunities Converge, Fashion InStyle Showcases Crossover Applications of New Materials on a Global Scale HONG KONG - April 28, 2026 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council (HKTDC) today officially opened its seven flagship lifestyle and licensing events. The Hong Kong Gifts & Premium Fair, Home InStyle and Fashion InStyle are being held at the Hong Kong Convention and Exhibition Centre (HKCEC), while the Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong at AsiaWorld-Expo, from today until 30 April.


Payfuture Provides the High-Volume Rails Profee Needs to Grow in Emerging Markets

April 28, 2026LONDON, UNITED KINGDOM - April 28, 2026 (NEWMEDIAWIRE) - Payfuture, the global payments company building financial infrastructure in emerging markets, today announced a strategic partnership with Profee, an international payments platform serving consumers across Europe and beyond. Through the partnership, Profee will leverage Payfuture’s infrastructure to enable INR-denominated payouts into India, supporting fast, reliable delivery of funds to both individual and business recipients via local payment rails.


Focus Universal Inc. Announces Completed Acquisition of 901 Corporate Center Drive

April 27, 2026WEST COVINA, CA - April 27, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) (the “Company”), a provider of patented hardware and software design technologies for the Internet of Things (IoT), 5G, and AI-driven SEC financial reporting automation software, announced today that Focus Universal Inc.


Greenland Energy (GLND) Signs Agreement With Halliburton for 2026 Jameson Land Basin Drilling Campaign

April 27, 2026LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - Greenland Energy (NASDAQ: GLND) announced it has signed an agreement with Halliburton for integrated consulting services and logistical management supporting its 2026 onshore drilling campaign in the Jameson Land Basin. The agreement covers planning, coordination, handling and transportation of equipment, services and goods, and includes comprehensive well and drilling services, forming a key part of the Company’s integrated Arctic operations strategy alongside prior agreements with Stampede Drilling and Desgagnés.


Cardio Diagnostics Holdings (CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management

April 27, 2026LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on addressing this need by developing advanced solutions that leverage artificial intelligence (“AI”) and multi-omic biomarkers to deliver actionable insights from a simple blood sample, enabling more informed and timely care cardiac care decisions.


LIXTE Biotechnology Holdings (LIXT) Unlocking New Potential in Precision Cancer Treatment

April 27, 2026LOS ANGELES, CA - April 27, 2026 (NEWMEDIAWIRE) - LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects,” reads a recent article.


Meridian Holdings to Announce First Quarter 2026 Financial Results

April 27, 2026LAS VEGAS, NV - April 27, 2026 (NEWMEDIAWIRE) - Meridian Holdings Inc. (NASDAQ: MRDN) ("Meridian Holdings" or the "Company"), a leading global operator and licensor of online sports betting and gaming platforms across over 20 regulated markets, today announced the Company will report its first quarter 2026 financial results before the market opens on Tuesday, April 28, 2026.


Catalyst Crew Technologies to Attend HLTH Europe 2026

April 27, 2026CARACAS, VENEZUELA - April 27, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced that Dr.


GeoVax Highlights Gedeptin® as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer Therapies

April 27, 2026 Positioned to Enhance Efficacy of Checkpoint Inhibitors and Next-Generation Oncology Modalities Across Solid Tumors ATLANTA, GA - April 27, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today highlighted the strategic positioning of its oncology asset, Gedeptin® (Ad/PNP), in the context of accelerating industry investment in next-generation in vivo cancer therapies.